Documentos relacionados

1. Long-term outcomes of very early treated infantile-onset Pompe disease with short-term steroid premedication: experiences from a nationwide newborn screening programme.
2. Health and economic outcomes of newborn screening for infantile-onset Pompe disease.
3. Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screening.
4. Population pharmacokinetic modeling and dosing simulation of avalglucosidase alfa for selecting alternative dosing regimen in pediatric patients with late-onset pompe disease.
5. Current avenues of gene therapy in Pompe disease.
6. In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's Disease.
7. [Analysis of lysosomal enzyme activity and genetic variants in a child with late-onset Pompe disease].
8. Early clinical phenotype of late onset Pompe disease: Lessons learned from newborn screening.
9. Outcome of Later-Onset Pompe Disease Identified Through Newborn Screening.
10. Infantile-onset Pompe disease in seven Mexican children.